ReSolution Latin America
Alfredo San Martin is an experienced professional in clinical research and regulatory affairs, currently serving as Principal CRA and Regulatory Specialist at ReSolution Latin America since July 2021. Prior experience includes roles at PRA Health Sciences as Clinical Research Associate III and managing operations at MDE SERVICES GROUP LIMITED as Country Manager, focusing on patient services and study team support. Alfredo has held project management positions at Peruvian Clinical Research and SM GLOBAL GROUP, where responsibilities included project coordination, client advisory, and compliance with local regulations. Alfredo's career also includes significant roles in prominent pharmaceutical companies such as AstraZeneca and Covance, emphasizing expertise in clinical research associate functions. Educational qualifications include a Medical Doctor degree from Universidad Nacional San Luis Gonzaga de Ica and a Project Management certification from the International Institute for Learning, Inc.
This person is not in any teams
This person is not in any offices
ReSolution Latin America
ReSolution Latin America is a clinical research solutions provider completely specialized in supporting our sponsors with their clinical development programs in the Latin American region. We provide our Sponsors with the opportunity to work with a credible regional niche CRO provider that is able to successfully: • Understand the expectations of international clients, as well as the requirements and demands of international clinical protocols. • Work locally and regionally to execute and deliver to these standards ensuring that the data that stems from Latin America can be integrated into the global data sets and used by our Sponsors for international regulatory purposes. Our expertise and infrastructure across the Latin American region enables us to offer our Sponsors access to all the advantages the region has to offer for clinical development (quality data, high enrollment potential, shortening of development timelines and cost) whilst minimizing potential pitfalls. Working exclusively through our own, fully-owned legal entities and with our own staff (no contractors/freelancers)- since our inception in 2007- we have enrolled in the region of 14,000 study participants across the board in terms of therapeutic areas, disease-types, product types and study complexities. We understand local and regional idiosyncrasies in a region where one size does not fit all.